Lv1
50 积分 2024-10-17 加入
Radiotheranostic landscape: A review of clinical and preclinical development
10小时前
待确认
Preclinical Evaluation of68Ga/177Lu-Labeled FAP-Targeted Peptide for Tumor Radiopharmaceutical Imaging and Therapy
10小时前
已完结
Feasibility, Biodistribution, and Preliminary Dosimetry in Peptide-Targeted Radionuclide Therapy of Diverse Adenocarcinomas Using 177Lu-FAP-2286: First-in-Humans Results
1个月前
已完结
Efficacy and Safety Evaluation of 177Lu-FAP-2286 in the Treatment of Advanced Lung Cancer
1个月前
已完结
Feasibility and therapeutic potential of [177Lu]Lu-FAPI-2286 in patients with advanced metastatic sarcoma
1个月前
已完结
ZT‐01: A novel somatostatin receptor 2 antagonist for restoring the glucagon response to hypoglycaemia in type 1 diabetes
1个月前
已完结
Improving the Theranostic Potential of Exendin 4 by Reducing the Renal Radioactivity through Brush Border Membrane Enzyme-Mediated Degradation
2个月前
已完结
Renal Brush Border Enzyme-Cleavable Linkages for Low Renal Radioactivity Levels of Radiolabeled Antibody Fragments
2个月前
已完结
Evolving Strategies for Target Selection for Antibody-Drug Conjugates
3个月前
已完结
Understanding and exploiting 5T4 oncofoetal glycoprotein expression
3个月前
已完结
皖公网安备34019202002308
